RPRX
Price
$31.28
Change
+$0.11 (+0.35%)
Updated
Apr 2 closing price
Capitalization
13.55B
34 days until earnings call
SGMO
Price
$0.65
Change
+$0.08 (+14.04%)
Updated
Apr 2 closing price
Capitalization
146.78M
27 days until earnings call
Ad is loading...

RPRX vs SGMO

Header iconRPRX vs SGMO Comparison
Open Charts RPRX vs SGMOBanner chart's image
Royalty Pharma
Price$31.28
Change+$0.11 (+0.35%)
Volume$4.64M
Capitalization13.55B
Sangamo Therapeutics
Price$0.65
Change+$0.08 (+14.04%)
Volume$17.73M
Capitalization146.78M
RPRX vs SGMO Comparison Chart
Loading...
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RPRX vs. SGMO commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPRX is a Hold and SGMO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (RPRX: $31.17 vs. SGMO: $0.65)
Brand notoriety: RPRX and SGMO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RPRX: 102% vs. SGMO: 341%
Market capitalization -- RPRX: $13.55B vs. SGMO: $146.78M
RPRX [@Biotechnology] is valued at $13.55B. SGMO’s [@Biotechnology] market capitalization is $146.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RPRX’s FA Score shows that 3 FA rating(s) are green whileSGMO’s FA Score has 0 green FA rating(s).

  • RPRX’s FA Score: 3 green, 2 red.
  • SGMO’s FA Score: 0 green, 5 red.
According to our system of comparison, RPRX is a better buy in the long-term than SGMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RPRX’s TA Score shows that 4 TA indicator(s) are bullish while SGMO’s TA Score has 4 bullish TA indicator(s).

  • RPRX’s TA Score: 4 bullish, 5 bearish.
  • SGMO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both RPRX and SGMO are a bad buy in the short-term.

Price Growth

RPRX (@Biotechnology) experienced а -7.67% price change this week, while SGMO (@Biotechnology) price change was -22.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

RPRX is expected to report earnings on May 07, 2025.

SGMO is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPRX($13.6B) has a higher market cap than SGMO($147M). RPRX YTD gains are higher at: 23.433 vs. SGMO (-35.961). RPRX has higher annual earnings (EBITDA): 1.56B vs. SGMO (-123.99M). RPRX has more cash in the bank: 1.77B vs. SGMO (39.2M). SGMO has less debt than RPRX: SGMO (27.7M) vs RPRX (7.61B). RPRX has higher revenues than SGMO: RPRX (2.26B) vs SGMO (52.3M).
RPRXSGMORPRX / SGMO
Capitalization13.6B147M9,252%
EBITDA1.56B-123.99M-1,255%
Gain YTD23.433-35.961-65%
P/E Ratio16.32N/A-
Revenue2.26B52.3M4,329%
Total Cash1.77B39.2M4,518%
Total Debt7.61B27.7M27,480%
FUNDAMENTALS RATINGS
RPRX vs SGMO: Fundamental Ratings
RPRX
SGMO
OUTLOOK RATING
1..100
1518
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
27100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
4790
P/E GROWTH RATING
1..100
15100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RPRX's Valuation (1) in the Pharmaceuticals Major industry is somewhat better than the same rating for SGMO (61) in the Biotechnology industry. This means that RPRX’s stock grew somewhat faster than SGMO’s over the last 12 months.

RPRX's Profit vs Risk Rating (27) in the Pharmaceuticals Major industry is significantly better than the same rating for SGMO (100) in the Biotechnology industry. This means that RPRX’s stock grew significantly faster than SGMO’s over the last 12 months.

RPRX's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as SGMO (99) in the Biotechnology industry. This means that RPRX’s stock grew similarly to SGMO’s over the last 12 months.

RPRX's Price Growth Rating (47) in the Pharmaceuticals Major industry is somewhat better than the same rating for SGMO (90) in the Biotechnology industry. This means that RPRX’s stock grew somewhat faster than SGMO’s over the last 12 months.

RPRX's P/E Growth Rating (15) in the Pharmaceuticals Major industry is significantly better than the same rating for SGMO (100) in the Biotechnology industry. This means that RPRX’s stock grew significantly faster than SGMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RPRXSGMO
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
52%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
UNI.X5.840698-0.427479
-6.82%
Uniswap cryptocurrency
BAT.X0.129405-0.010636
-7.59%
Basic Attention Token cryptocurrency
XVG.X0.004216-0.000357
-7.80%
Verge cryptocurrency
DNT.X0.023480-0.002202
-8.57%
district0x cryptocurrency
BURGER.X0.008631-0.003136
-26.65%
BurgerCities cryptocurrency

RPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
+0.35%
AXON - RPRX
48%
Loosely correlated
+3.18%
MDGL - RPRX
31%
Poorly correlated
+3.28%
ARRY - RPRX
30%
Poorly correlated
+1.65%
QURE - RPRX
29%
Poorly correlated
+7.16%
SLGL - RPRX
28%
Poorly correlated
-1.49%
More

SGMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with AXON. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
+14.58%
AXON - SGMO
51%
Loosely correlated
+3.18%
ARRY - SGMO
48%
Loosely correlated
+1.65%
BCRX - SGMO
46%
Loosely correlated
+2.48%
RPRX - SGMO
45%
Loosely correlated
+0.35%
AGEN - SGMO
43%
Loosely correlated
+1.87%
More